Please login to the form below

Not currently logged in
Email:
Password:

RedoxTherapies

This page shows the latest RedoxTherapies news and features for those working in and with pharma, biotech and healthcare.

Juno cleared to restart CAR-T trial after deaths

Juno cleared to restart CAR-T trial after deaths

Buys RedoxTherapies. Meanwhile, Juno has added to its pipeline with a deal to acquire Boston-based biotech RedoxTherapies and lead compound vidapenant, a small-molecule adenosine 2A receptor antagonist that is ... The company is paying $10m upfront for

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera

We live in a time of participation – patients actively involved in their own care recover faster and live longer....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics